Saad Kareem 4
4 · GeneDx Holdings Corp. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Saad Kareem
Chief Business Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-01-01−273→ 2,455 total→ Class A Common Stock (273 underlying) - Exercise/Conversion
Class A Common Stock
2024-01-01+273→ 24,219 total
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
- [F2]6.25% vest in quarterly installments over the 4-year period on April 4, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date